《大行報告》瑞信降中國有贊(08083.HK)評級至「跑輸大市」 目標價升至0.16元
瑞信發表研究報告,引述中國有贊(08083.HK)管理層稱業務有一些復甦,隨著內地疫情減退,5月非快手GMV按年升幅較4月有所加快。但由於商戶經營環境困難,獲客仍存在挑戰。由於6月非快手GMV復甦可見度高,管理層重申今年全年度GMV持平指引,及專注於成本減省。
該行更新估值方法,以預測市銷率3.4倍計,料公司非快手業務可支持今年下半年及往後業務增長,目標價由0.12元升至0.16元,但投資評級由「中性」降至「跑輸大市」,因過去一個月股價累升約120%,跑贏微盟(02013.HK)同期逾30%升幅,但沒有任何基本面改變支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.